Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | +2.80% | +0.50% | -63.89% |
Apr. 18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Apr. 18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.08M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
-0.56
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Moleculin Biotech, Inc.
1 day | +2.80% | ||
1 week | +0.50% | ||
Current month | -21.32% | ||
1 month | -40.82% | ||
3 months | -43.32% | ||
6 months | -49.59% | ||
Current year | -63.89% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 15-07-27 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 16-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Michael Cannon
BRD | Director/Board Member | 78 | 15-06-30 |
John Climaco
BRD | Director/Board Member | 55 | 17-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 4.65 | +2.80% | 10,562 |
24-04-18 | 4.524 | +5.69% | 49,640 |
24-04-17 | 4.28 | 0.00% | 10,408 |
24-04-16 | 4.28 | -4.04% | 15,943 |
24-04-15 | 4.46 | -3.61% | 20,009 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.89% | 10.08M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- MBRX Stock